|
PKD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.596800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.291800E-02 |
| Normal-vs-Stage2 |
3.969500E-02 |
| Normal-vs-Stage3 |
8.410100E-04 |
| Normal-vs-Stage4 |
1.178060E-04 |
| Stage1-vs-Stage2 |
4.505600E-01 |
| Stage1-vs-Stage3 |
1.170460E-02 |
| Stage1-vs-Stage4 |
1.137200E-03 |
| Stage2-vs-Stage3 |
4.733000E-01 |
| Stage2-vs-Stage4 |
1.826020E-01 |
| Stage3-vs-Stage4 |
3.579800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.335000E-03 |
| Normal-vs-AfricanAmerican |
6.998400E-02 |
| Normal-vs-Asian |
9.237000E-01 |
| Caucasian-vs-AfricanAmerican |
4.137400E-01 |
| Caucasian-vs-Asian |
1.290760E-01 |
| AfricanAmerican-vs-Asian |
2.737200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.574500E-04 |
| Normal-vs-Female |
5.813800E-02 |
| Male-vs-Female |
9.064800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.152750E-01 |
| Normal-vs-Age(41-60Yrs) |
1.403740E-02 |
| Normal-vs-Age(61-80Yrs) |
2.039100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.973800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.367400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.618200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.410400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.400200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.919800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.983800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.665600E-01 |
| Normal-vs-Grade 2 |
8.542100E-02 |
| Normal-vs-Grade 3 |
3.181000E-04 |
| Normal-vs-Grade 4 |
1.62867999999872E-05 |
| Grade 1-vs-Grade 2 |
1.128190E-01 |
| Grade 1-vs-Grade 3 |
4.220200E-04 |
| Grade 1-vs-Grade 4 |
1.245290E-04 |
| Grade 2-vs-Grade 3 |
2.247500E-04 |
| Grade 2-vs-Grade 4 |
1.57167000000014E-05 |
| Grade 3-vs-Grade 4 |
4.620300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.593200E-01 |
| Normal-vs-ccB subtype |
2.049700E-04 |
| ccA subtype-vs-ccB subtype |
8.01169999999907E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.541500E-03 |
| Normal-vs-N1 |
2.119200E-01 |
| N0-vs-N1 |
9.978800E-01 |
|
|
